Table 4.
Copy Number Detection for Selected Hybrid Alleles Composed of Portions of CYP2D6 and CYP2D7
Allele | Allele functional status† | Reference material available | Multiethnic allele frequency | Hybrid type | 5′ UTR‡ | Exon 1‡ | Intron 2‡ | Intron 5‡ | Intron 6‡ | Exon 9‡ |
---|---|---|---|---|---|---|---|---|---|---|
∗4.013 (∗4N) | No function | 2D6-2D7 | Yes | Yes | Yes | Yes | Yes | No | ||
∗13 | No function | Yes | 0%–0.4% | 2D7-2D6 | No | No | Yes/no | Yes/no | Yes/no | Yes§ |
∗36 | No function | Yes | 0%–1.2% | 2D6-2D7 | Yes | Yes | Yes | Yes | Yes | No |
∗68 | No function | Yes | Not available | 2D6-2D7 | Yes | Yes | No¶ | No¶ | No¶ | No |
∗83 | Uncertain function | Yes | Not available | 2D6-2D7 | Yes | Yes | Yes | Yes | Yes | No |
CPIC, Clinical Pharmacogenetics Implementation Consortium; HGVS, Human Genome Variation Society.
Allele functional status corresponds to CPIC clinical allele function assignments as listed in the CYP2D6 Allele Functionality Table available through PharmGKB (https://www.pharmgkb.org/page/cyp2d6refmaterials, last accessed June 2, 2021); these function assignments are also displayed by the Pharmacogene Variation Consortium.
Signal present on copy number analysis for this allele.
A hybrid with a switch to CYP2D6 past exon 9 has been described in tandem arrangements; these are technically also CYP2D7-2D6 hybrids and produce no signal across any of the listed regions.
It cannot be ruled out that rare/undefined hybrids switch in different regions affecting the copy number call in that region.